Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.96 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.59 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.59 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | IDH1 | O75874 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| E1501 SCHEMBL43745 | 0.98 | ALDH1A1 (1.00) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| E1501 SCHEMBL14031569 | 0.98 | ALDH1A1 (1.00) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| E1501 SCHEMBL28201296 | 0.98 | ALDH1A1 (1.00) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| E1501 SCHEMBL901210 | 0.98 | ALDH1A1 (1.00) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| E1501 SCHEMBL1256238 | 0.96 | ALDH1A1 (0.96) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| E1501 SCHEMBL18954294 | 0.96 | ALDH1A1 (0.96) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| E1501 SCHEMBL28928069 | 0.96 | ALDH1A1 (0.96) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| E1501 SCHEMBL30579458 | 0.96 | ALDH1A1 (0.96) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| E1501 SCHEMBL14334870 | 0.96 | ALDH1A1 (0.96) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| E1501 SCHEMBL27261610 | 0.96 | ALDH1A1 (0.96) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115326992-B | Method for detecting influence of different migration paths on barrier performance of lining paper | 上海烟草集团有限责任公司 | 2024-05-31 | — | — | CN | disclosed |
| EP-4330853-A1 | SYSTEMS AND METHODS FOR CHEMICAL AND BIOLOGICAL AUTHENTICATION | Salvus, LLC (US) | 2024-03-06 | — | — | EP | disclosed |
| EP-2646533-B2 | FABRIC CONDITIONERS | UNILEVER IP HOLDINGS B V (NL) | 2023-07-05 | — | — | EP | disclosed |
| CN-115836061-A | Odorants and compositions comprising odorants | 丝趣科尔卡有限公司 | 2023-03-21 | — | — | CN | disclosed |
| WO-2022232096-A1 | SYSTEMS AND METHODS FOR CHEMICAL AND BIOLOGICAL AUTHENTICATION | SALVUS, LLC (US) | 2022-11-03 | — | — | WO | disclosed |
| CN-114920645-A | Synthetic method of alpha-methoxy methyl acetate derivative | 常州大学 | 2022-08-19 | — | — | CN | disclosed |
| CN-112334442-A | Carboxylate compound, method for producing same, composition, and perfume composition | 三菱瓦斯化学株式会社 | 2021-02-05 | — | — | CN | disclosed |
| EP-2748297-B1 | IMPROVEMENTS RELATING TO POLYMERS, DEPOSITION AIDS, TARGETED BENEFIT AGENTS AND SUBSTRATE TREATMENT COMPOSITIONS | UNILEVER NV (NL) | 2021-01-20 | — | — | EP | disclosed |
| EP-2188364-B2 | FABRIC TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2020-12-30 | — | — | EP | disclosed |
| EP-3188709-B1 | TRANSPARENT COSMETIC AND PERSONAL CARE COMPOSITIONS | UNILEVER PLC (GB) | 2020-10-14 | — | — | EP | disclosed |
| WO-2009037060-A1 | IMPROVEMENTS RELATING TO FABRIC TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2009-03-26 | — | — | WO | disclosed |
| WO-2009030601-A1 | IMPROVEMENTS RELATING TO FABRIC CONDITIONERS | UNILEVER PLC (GB) | 2009-03-12 | — | — | WO | disclosed |
| WO-2009030600-A1 | IMPROVEMENTS RELATING TO FABRIC CONDITIONERS | UNILEVER PLC (GB) | 2009-03-12 | — | — | WO | disclosed |
| WO-2009016123-A1 | IMPROVEMENTS RELATING TO PERFUMES | UNILEVER PLC (GB) | 2009-02-05 | — | — | WO | disclosed |
| WO-2008145547-A1 | IMPROVEMENTS RELATING TO PERFUME PARTICLES | UNILEVER PLC (GB) | 2008-12-04 | — | — | WO | disclosed |
| US-20080200554-A1 | Cycloaklyldiene-(Ortho Substituted Phenyl)-Acetonitriles and Their Use as Odorants | GIVAUDAN SA (CH) | 2008-08-21 | — | — | US | disclosed |
| EP-1954796-A1 | IMPROVEMENTS RELATING TO FABRIC TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2008-08-13 | — | — | EP | disclosed |
| EP-1890999-A1 | CYCLOAKYLIDENE- (ORTHO SUBSTITUTED PHENYL) -ACETONITRILES AND THEIR USE AS ODORANTS | Givaudan SA (CH) | 2008-02-27 | — | — | EP | disclosed |
| WO-2007062833-A1 | IMPROVEMENTS RELATING TO FABRIC TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2007-06-07 | — | — | WO | disclosed |
| WO-2006133592-A1 | CYCLOAKYLIDENE- (ORTHO SUBSTITUTED PHENYL) -ACETONITRILES AND THEIR USE AS ODORANTS | GIVAUDAN SA (CH) | 2006-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200554-A1 | Cycloaklyldiene-(Ortho Substituted Phenyl)-Acetonitriles and Their Use as Odorants | OR10J3, OR51E2, OPRD1 | ALDH1A1 1402/4885TDP1 4421/4885MAPK1 808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.